Skip to main content
See every side of every news story
Published loading...Updated

Brokerages Set Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) PT at $24.71

Summary by ETF Daily News
Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) have been assigned a consensus rating of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ETF Daily News broke the news on Friday, August 29, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal